The bottom line
Raw Whey's creatine sits at the price floor of the Indian market. No documentation exists to verify what is inside. AS-IT-IS costs ₹0.8 more per dose and has a NABL COA. That ₹0.8 is hard to argue against.
Raw Whey is an online-first Indian supplement brand that positions on stripped-back, budget-tier products — their name is the positioning. Their creatine monohydrate (250g, unflavoured) contains one ingredient at 5g per scoop. The label is clean in the sense that it makes no inflated claims — it describes monohydrate and nothing else.
The documentation picture is clear: there is none. No published COA, no third-party batch test, no raw material source disclosure, no certification mark. Raw Whey's creatine is one of many budget-domestic products where the buyer is extending trust based on price and label simplicity rather than independent verification.
The pragmatic question: how much is documentation worth at the margin? At ₹10.0/dose, Raw Whey costs ₹0.8 more than AS-IT-IS (₹9.2), which publishes a NABL-accredited COA. The documentation gap is enormous. The price gap is trivial. This arithmetic makes Raw Whey a difficult buy unless AS-IT-IS is genuinely out of stock or unavailable in your region — in which case, Raw Whey is a serviceable fallback at similar pricing.
The budget tier transparency gap
Raw Whey occupies a category with many domestic brands at similar price points — typically ₹449–₹599 for 250g. Across this tier, the documentation pattern is consistent: single-ingredient labels, no published COAs, no named raw material suppliers, no certifications. The question is whether the price justifies accepting this documentation floor.
The risk profile for undocumented creatine monohydrate is specific:
- Adulteration risk: Creatine is cheap enough that sophisticated adulteration is economically irrational. The incentive structure that drives adulteration in protein powder (cheaper nitrogen sources substituting for expensive whey) does not apply at the same scale to creatine. This moderates but does not eliminate the risk.
- Quality variation risk: Without documentation, batch-to-batch consistency is unknown. If the raw material supplier changes, the buyer has no signal. For creatine — where creatinine content and moisture level affect efficacy and safety — consistency matters.
- Heat/humidity degradation risk: Indian supply chains expose supplements to temperatures and humidity levels that accelerate creatine degradation to creatinine. An undocumented product has no incoming quality check that would catch degraded batches.
Over 50 doses (one 250g pouch), that is ₹40. Over a year of daily supplementation (365 doses), the gap is ₹292. The NABL-accredited COA that AS-IT-IS provides is not worth zero; it is worth at least ₹292 per year in the expected value of avoided degraded batches and contaminated product. Most buyers who run this calculation switch to AS-IT-IS.
Who this is for
Consider if: AS-IT-IS Creatine is genuinely unavailable — out of stock, delivery to your pin code not feasible — and you need a budget creatine today. Raw Whey is a reasonable stopgap at the same price tier.
Consider if: You have used Raw Whey's other products (protein specifically) and have had positive experiences. Brand consistency is a weak proxy for quality, but it is not nothing.
Not recommended if: AS-IT-IS is available to you. The price difference (₹0.8/dose) is marginal and the documentation difference (NABL COA vs nothing) is substantial.
Not recommended if: You supplement creatine long-term and want confidence in batch consistency. Without documentation, you have no mechanism to detect a quality shift.
Our score — rubric breakdown
Creatine monohydrate. The ingredient evidence base is the same regardless of brand or price point. More than 1,000 RCTs. Score does not vary by brand.
Creatine monohydrate, correct form, single ingredient. Particle size not specified. Standard score for unspecified-particle domestic monohydrate products.
No documentation of any kind. No published COA, no certification mark, no named raw material supplier. This is the documentation floor. The score of 3 rather than 1 reflects that (a) the product has been in market without documented quality incidents, (b) the adulteration incentive structure for creatine is lower than for protein, and (c) the simple label makes false claims unlikely. But unverified is unverified.
₹10.0/dose at the price floor for the domestic creatine market. This is genuinely good value if the product contains what it says. The score is tempered by the fact that AS-IT-IS (₹9.2/dose, NABL COA) is cheaper and better documented — Raw Whey's value proposition is weaker than it appears because a directly comparable but better-documented alternative exists at a lower price.
Single ingredient, correct dose, no inflated marketing claims. The "Raw Whey" brand name implies an unprocessed, no-frills approach — which the product delivers on the label. No misleading certifications or credential marks. Deduction for providing no documentation at all — a label that makes no false claims but also provides no verifiable true claims sits in the middle of this dimension.
Score formula: (9.5 × 0.30) + (8.0 × 0.20) + (3.0 × 0.20) + (7.5 × 0.15) + (7.0 × 0.15) = 2.85 + 1.60 + 0.60 + 1.125 + 1.05 = 7.225 → 7.2 / 10
References
- Kreider RB, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18.
- Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80(3):1107–1213.
- NABL. National Accreditation Board for Testing and Calibration Laboratories. nabl.gov.in. Accessed Jul 2026.